- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Immunomedics names new CEO
Radiopharmaceutical developer Immunomedics has appointed Robert DeLuccia as CEO to take over duties previously handled by the company's founder, Dr. David Goldenberg. DeLuccia formerly served as marketing vice president at both Pfizer Laboratories and
Radiopharmaceutical developer Immunomedics has appointed Robert DeLuccia as CEO to take over duties previously handled by the company's founder, Dr. David Goldenberg. DeLuccia formerly served as marketing vice president at both Pfizer Laboratories and Winthrop Pharmaceuticals, as well as U.S. president of Sanofi Winthrop Pharmaceuticals.
DeLuccia will assume immediate management of the company, allowing Goldenberg to center his efforts on Immunomedics' cancer therapeutics research and other projects. DeLuccia's responsibilities will include developing strategies to best use the company's technology and personnel, according to the Morris Plains, NJ-based firm.
Immunomedics manufactures and distributes antibody-based cancer and infection imaging agents throughout the U.S. and Europe. Its products include CEA-Scan, for the detection of colorectal cancer, and LeukoScan, for the diagnosis of bone infection. LeukoScan is currently under review by the Food and Drug Administration.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
